Trials / Recruiting
RecruitingNCT07256145
Comparison Between the Efficacy of Ultrasound-guided Erector Spinae Plane Block and Conventional Treatment for Pain Management in Patients With Post-herpetic Neuralgia
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The present study aims to evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia, patient satisfaction, and record any complications post-injection.
Detailed description
The current study will be conducted as a single-blinded prospective randomized controlled study to evaluate the efficacy of ultrasound-guided erector spinae plane block with steroids to relieve pain in cases of post-herpetic neuralgia. All patients will be evaluated by: * Full history taking: including age, sex, presence of co-morbid conditions as well as the presenting complaint. * Clinical examination and routine lab investigations that include: * Complete blood count (CBC). * Fasting blood glucose (FBG). * Coagulation profile (bleeding time, prothrombin time, prothrombin activity, international normalized ratio). Measurements: Patients will be followed up at 24 hours, 1 week, and 6 weeks after injection. The following measurements will be recorded: 1. Pain will be assessed pre- and post-injection using VAS score at 24 hours, 1 week, and 6 weeks post-injection. 2. Need for analgesic intake post-injection will be assessed at the follow-up periods. 3. Patient satisfaction using the SAPS score. 4. Complications post-injection as pain, irritation or infection will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | erector spinae plane block | erector spinae plane block with steroids |
Timeline
- Start date
- 2025-08-01
- Primary completion
- 2026-02-01
- Completion
- 2026-03-01
- First posted
- 2025-12-01
- Last updated
- 2025-12-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07256145. Inclusion in this directory is not an endorsement.